|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/113 | |
| A61K 31/713 |
| (11) | Patento numeris | 2504435 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10785571.0 |
| Europos patento paraiškos padavimo data | 2010-11-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-10-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-11-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/058123 |
| Data | 2010-11-25 |
| (87) | Numeris | WO 2011/066475 |
| Data | 2011-06-03 |
| (30) | Numeris | Data | Šalis |
| 264668 P | 2009-11-26 | US | |
| 295721 P | 2010-01-17 | US | |
| 372072 P | 2010-08-09 | US |
| (72) |
AVKIN-NACHUM, Sharon, IL
|
| (73) |
Quark Pharmaceuticals, Inc.,
7999 Gateway Boulevard, Suite 310, Newark, CA 94560,
US
|
| (54) | SIRNA COMPOUNDS COMPRISING TERMINAL SUBSTITUTIONS |
| SIRNA COMPOUNDS COMPRISING TERMINAL SUBSTITUTIONS |